Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Abaloparatide - Ipsen/Radius Health

Next Previous
X
Search
Drug Profile

Abaloparatide - Ipsen/Radius Health

Alternative Names: Abaloparatide patch; Abaloparatide-SC; Abaloparatide-sMTS; Abaloparatide-TD; BA-058; BA-058-SC; BA-058-TD; BIM-44058; Eladynos; ITM-058; Ostabalo; Ostabaro; PBK-L2201; PBK_L2201; PTHrP; Synthetic human parathyroid hormone 37-70 analogue - Ipsen; TYMLOS

Latest Information Update: 04 Dec 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator 3M Drug Delivery Systems; Biomeasure Inc; Ipsen
  • Developer Radius; Radius Health Inc.; Teijin Pharma
  • Class Calcium regulators; Osteoporosis therapies; Peptide hormones
  • Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor type 1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Postmenopausal osteoporosis
  • Registered Male osteoporosis; Osteoporosis

Most Recent Events

  • 01 Jun 2024 Efficacy data from phase III ATOM trial in Male osteoporosis presented at the 106th Annual Meeting of the Endocrine Society(ENDO-2024)
  • 07 Dec 2023 PharmaBio Korea plans the phase III Bridge trial for Osteoporosis (In adults, In the elderly) in South Korea (SC) (NCT06154187)
  • 20 Mar 2023 Registered for Postmenopausal osteoporosis in European Union (SC)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top